CIPLA vs DRREDDY
Head-to-head DCF comparison · Cipla Limited vs Dr. Reddy's Laboratories Limited
It's a tie
CIPLA and DRREDDY are evenly matched on the 4 headline metrics.
CIPLA
Cipla Limited
Pharma
₹1,381
Near Fair ValueDRREDDY
Dr. Reddy's Laboratories Limited
Pharma
₹1,280
Near Fair Value| Metric | CIPLA | DRREDDY |
|---|---|---|
| Verdict | Near Fair Value | Near Fair Value |
| YieldIQ Score | 45/100 | 55/100 |
| Fair Value | ₹1,218 | ₹1,429 |
| Current Price | ₹1,381 | ₹1,280 |
| Discount to FV | -11.8% | +11.7% |
| Moat | Narrow | Narrow |
| Piotroski F-Score | 5/9 | 4/9 |
| ROE | 11.3% | 11.4% |
| Debt / Equity | 0.02 | 0.21 |
| EV / EBITDA | 18.1× | 14.2× |
| Market Cap | ₹1.12 Lakh Cr | ₹1.07 Lakh Cr |
Run the full interactive analysis
DCF sliders, sensitivity tables, peer screens, watchlists — free to start.
Sign up free →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst.